1 - 10 of 45 articles
This Patient Page provides information on hormone therapy–related hot flashes and their management.
This cohort study examines recurrence outcomes in patients with fully resected gastroenteropancreatic neuroendocrine tumors.
Key PointsQuestionWhat is the most appropriate primary end point in phase 2 trials of checkpoint inhibitors?
FindingsIn this systematic review and meta-analysis of phase 2 and phase 3 trials of checkpoint inhibitors in advanced solid cancers, response rate correlated poorly with overall...
This secondary analysis of a randomized clinical trial evaluates the prognostic value of 6 multigene signatures in women with early estrogen receptor–positive breast cancer who have received 5 years of endocrine therapy.
Read and print from thousands of top scholarly journals.
Continue with Facebook
Sign up with Google
Log in with Microsoft
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Sign Up Log In
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don’t already have one.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.